About us

Deversify's team is diverse and multi-disciplinary. It is in our name.

How we work

The pandemic years have meant several lessons about organizational processes and team building. By acknowledging the opportunity to work remotely, we reach the world in the search for new employees and special competences. We simultaneously acknowledge the importance of physical meetings. We work digitally and remotely as well as on site at our assembly unit in Söderhamn. Deversify's work has received attention over the years. For this we are sincerely grateful. These are some of our achievements.

Deversify’s work has received recognition over the years. For this, we are sincerely grateful. These are some of our achievements.

In 2018, Deversify won the Bona Postulate Prize, a local business prize in Uppsala County, Sweden, for companies with strong growth potential.

In 2019, we became winner of the Best Startup within Health & Wellbeing at the Matcher Conference in Bologna, Italy. The same year, 2019, we were also selected, among 1200 screened companies, as one of only ten participants at the Katapult Accelerator in Oslo, Norway. Katapult invests in and accelerate tech startups with a positive impact on the world by providing training, technical expertise, financing, and also by giving access to their extensive global network. This programme included three months, on site in Oslo, of education and preparation for firm development and growth.

In 2020, we were selected for the Uppsala Innovation Centre (UIC) Business Accelerator Programme. UIC is one of the world’s leading business incubators according to UBI Global. They support innovative startups and growth companies through one-to-one tailor-made business development programs. UIC provide networks, access to financing, and necessary knowledge required for shortened time-to-market.

In 2021, Deversify had the pleasure to be selected for the Swedish-French Accelerator Programme organised by EIT Health. The EU sponsored EIT Health Programme is a one-year program which offers a combination of mentoring, and onsite and online training sessions, to validate Deversify’s solutions and fit to the French market.

In 2022, Deversify was handpicked to participate in EIT Health’s prestigious Bridgehead Programme. The initiative is one of EIT Health’s flagship projects and facilitates market entry for European health entrepreneurs by pairing them with top incubators and accelerators.

Recognition

Together with colleagues and collaborators, we have been internationally recognized with the following awards and nominations.

“We founded Deversify to build new types of devices and sensors that measure biomarkers helping people to manage and prevent lifestyle diseases. Our R&D team is uniquely positioned to apply physics using sensors, smartphones, cloud services and AI to improve public health globally.”

Quote

Anders Murman
Co-founder & CEO
Deversify

Our journey

  • 2023

    Deversify expanded into several new countries with Acetrack

  • 2022

    Deversify selected for EIT health´s Bridgehead programme 2022

  • 2021

    Agreement with RLVNT for Acetrack distribution in EU
    Elitista education platform is acquired
    Selected for the EIT Health Accelerator Programme in France

  • 2020

    Selected for the Uppsala Innovation Centre Business Accelerator Programme
    Expansion in Scandinavia and UK

  • 2019

    Selected for the Katapult Accelerator
    Winner of “Best Startup within Health & Wellbeing” in Bologna

  • 2018

    Winner of the Bona Postulata Award
    Acetrack sold via the Amazon Global Seller Account

  • 2017

    First fully functional prototypes of Acetrack built

  • 2016

    Deversify AB was founded

Vårt team

Deversify finns på två platser i Sverige. Vi har huvudkontoret på SLU (Sveriges lantbruksuniversitet) campus i Uppsala för att ta del av den akademiska atmosfären av affärs- och forskningsmöjligheter. Vi har även vårt hårdvarucenter i Söderhamn som täcker montering och leverans.

Personal

Åsa Lang
COO, Co-founder, Board member

Anders Murman
CEO, Co-founder

Mimmi Jinnefalk
Production Manager

Sara Rogers
CMO

Hanna Murman
SoMe and Communications Coordinator

Ewa Meurk
Business Development, Elitista

Lena Söderström
Business Advisor

Our board

Åsa Lang
COO, Co-founder, Board member

Johan Willdeck
COB

Martin Engberg
Board Member

Advisors

Christina Öberg
Prof. Business Administration, Advisor

Contact

Any questions at all? Please contact us here.

If you have any questions or want to know more, please send us an email and we’ll help you as soon as possible.

The Sugarfree Day 2024 a success!

2024.10.12

Wrapping up this year's Sugarfree Day, we conclude we had a sold out A-huset and many more online. The adjacent exhibition displayed all aspects of metabolic health initiatives, including our own Metabolic Screening, Acetrack and book sales (that sold out!)

Ringing the bell at Nasdaq!

2024.09.06

What a day for us all - thanks for everyone involved throughout the years!

Distribution agreement with Belgian digital pharmacy Newpharma

2024.08.20

Uppsala, 20240820 — Deversify Health AB (publ) ("Deversify"), which was recently listed on Nasdaq First North through a reverse acquisition, has signed a distribution agreement with Belgian pharmacy chain Newpharma SRL ("Newpharma") and their subsidiary Smart Value Distribution SRL for resale of Acetrack in central Western Europe. As far as resellers are concerned, Deversify currently only has such dealers in Sweden and offers Acetrack in the rest of Europe and the world exclusively through its own channels. The agreement with Newpharma means that two new milestones are achieved: part resale in central Europe and part distribution to end customers through digital and physical pharmacies. Newpharma is a fast-growing pharmacy chain with e-commerce in France, Belgium, the Netherlands, Luxembourg, Germany, Austria and Switzerland and was among other things voted France's best e-pharmacy in 2023. Their distribution company also delivers to other pharmacies around the region, in in most cases physical pharmacies. Newpharma also has a close connection with Yooboo, which is a Belgian opinion leader around the importance of lifestyle changes. "The fact that we are starting to find local sales channels and logistics partners out in continental Europe is a good sign that the demand for solutions such as Acetrack offers is rising," says Anders Murman, CEO of Deversify. "The fact that it also comes from an actor such as Newpharma, with a modern approach to lifestyle changes and which tries to change how the pharmacy's role in society can become more holistic, is gratifying as it is completely in line with Deversify's view of how health improvements can be achieved without necessarily always rely on medicine."

SPA for reverse take-over of Euroafrica Digital Ventures announced

2024.02.29

Read more in the press release segment (in Swedish)